I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lok, AS
12
results:
Search for persons
X
Format
Online (12)
Mediatypes
Articles (Online) (1)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
GBV-C and HGV: A new hepatitis virus?:
McDonnell, WM
;
Lok, AS
Gastroenterology. 111 (1996) 6 - p. 1776-1778 , 1996
Link:
https://doi.org/10.1016/..
?
2
Incidence and Prediction of HBsAg Seroconversion in a Prosp..:
Terrault, NA
;
Wahed, AS
;
Feld, JJ
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943823/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
3
Durability of Hepatitis B Surface Antigen Loss With Nucleot..:
Lok, AS
;
Zoulim, F
;
Dusheiko, G
...
issn:2471-254X. , 2020
Link:
http://hdl.handle.net/11..
?
4
Psychometric properties of the PROMIS short form measures i..:
Evon, DM
;
Amador, J
;
Stewart, P
...
qt6dd2b7f9. , 2018
Link:
https://escholarship.org..
?
5
A research agenda for curing chronic hepatitis B virus infe..:
Alter, H
;
Block, T
;
Brown, N
...
issn:0270-9139. , 2018
Link:
http://hdl.handle.net/11..
?
6
Update on Prevention, Diagnosis, and Treatment and of Chron..:
Terrault, NA
;
Lok, AS
;
McMahon, BJ
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975958/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
7
Entecavir versus lamivudine for patients with HBeAg-negativ..:
Fernandes, L
;
Wilber, R
;
Lok, AS
...
New England Journal of Medicine. , 2006
Link:
https://doi.org/10.1056/..
?
8
Guidance for design and endpoints of clinical trials in chr..:
Cornberg, M
;
Lok, AS-F
;
Terrault, NA
..
https://discovery.ucl.ac.uk/id/eprint/10095195/1/hep.31030.pdf. , 2020
Link:
https://discovery.ucl.ac..
?
9
Guidance for design and endpoints of clinical trials in chr..:
Cornberg, M
;
Lok, AS-F
;
Terrault, NA
..
Hepatology. , 2019
Link:
https://qmro.qmul.ac.uk/..
?
10
Identification of LukPQ, a novel, equid-adapted leukocidin ..:
Koop, G
;
Vrieling, M
;
Storisteanu, DML
...
Scientific Reports. , 2016
Link:
http://hdl.handle.net/10..
?
11
What is the prognostic significance of acrometastases?:
Baltazard, T
;
Arnault, JP
;
Dillied, AS
..
qt53k593w6. , 2015
Link:
https://escholarship.org..
?
12
Cardiorenal end points in a trial of aliskiren for type 2 d..:
Parving HH
;
Brenner BM
;
McMurray JJ
...
info:eu-repo/semantics/altIdentifier/pmid/23121378. , 2012
Link:
http://hdl.handle.net/23..
1-12